Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Paclitaxel"" wg kryterium: Temat


Tytuł:
Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery.
Autorzy:
Chen Y; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Han L; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Qiu X; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Wang M; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Chen Z; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Cai Y; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Xin Y; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Lv Y; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Hu A; Center of Animal Laboratory, Xuzhou Medical University, Xuzhou, China.
Chai D; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Li L; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Li H; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Zheng J; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Wang G; Cancer Institute, Xuzhou Medical University, Xuzhou, China.; Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 728-742.
Typ publikacji:
Journal Article
MeSH Terms:
Albumin-Bound Paclitaxel*
Nanoparticles*
Animals ; Cell Line, Tumor ; Drug Delivery Systems ; Mice ; Neutrophils ; Paclitaxel
Czasopismo naukowe
Tytuł:
Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer.
Autorzy:
Wang H; Master of Medicine, Department of Gynaecology, Harbin Medical University Cancer Hospital, No. 150, Haping Road, Harbin, Heilongjiang, 150081, People's Republic of China.
Fan L; Master of Medicine, Department of Gynaecology, Harbin Medical University Cancer Hospital, No. 150, Haping Road, Harbin, Heilongjiang, 150081, People's Republic of China.
Wu X; Master of Medicine, Department of Gynaecology, Harbin Medical University Cancer Hospital, No. 150, Haping Road, Harbin, Heilongjiang, 150081, People's Republic of China.
Han Y; Master of Medicine, Department of Gynaecology, Harbin Medical University Cancer Hospital, No. 150, Haping Road, Harbin, Heilongjiang, 150081, People's Republic of China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2022 Jun 11; Vol. 22 (1), pp. 224. Date of Electronic Publication: 2022 Jun 11.
Typ publikacji:
Journal Article
MeSH Terms:
Albumin-Bound Paclitaxel*/therapeutic use
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/etiology
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/therapeutic use ; Carcinoma, Ovarian Epithelial/drug therapy ; Female ; Humans ; Neoadjuvant Therapy ; Paclitaxel/therapeutic use ; Quality of Life ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Camrelizumab (SHR-1210) with carboplatin and albumin-binding paclitaxel in patients with metastatic or recurrent cervical cancer: An open-label, phase 2 trial.
Autorzy:
Zhang X; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Chen J; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Liu N; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Wang Q; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Wu Q; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Gao F; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Sang Y; Department of Gynecologic Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Wang P; Department of Gynecology, People's Hospital of Zouping City, Binzhou, Shandong, People's Republic of China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Apr; Vol. 18 (2), pp. 482-487.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Albumin-Bound Paclitaxel*
Uterine Cervical Neoplasms*/pathology
Albumins ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin ; Chronic Disease ; Female ; Humans ; Paclitaxel/therapeutic use ; Prospective Studies
Czasopismo naukowe
Tytuł:
Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay.
Autorzy:
Hwang D; Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, United States.
Vinod N; Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, United States; Joint UNC/NC State Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, 27599, United States.
Skoczen SL; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD, 21702, United States.
Ramsey JD; Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, United States.
Snapp KS; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD, 21702, United States.
Montgomery SA; Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, United States.
Wang M; Biomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27514, United States.
Lim C; Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, United States.
Frank JE; Biomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27514, United States.
Sokolsky-Papkov M; Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, United States.
Li Z; Biomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27514, United States.
Yuan H; Biomedical Research Imaging Center, Department of Radiology, and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27514, United States.
Stern ST; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD, 21702, United States.
Kabanov AV; Center for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, NC, 27599, United States; Laboratory of Chemical Design of Bionanomaterials, Faculty of Chemistry, M. V. Lomonosov Moscow State University, Moscow, 119992, Russia. Electronic address: .
Pokaż więcej
Źródło:
Biomaterials [Biomaterials] 2021 Nov; Vol. 278, pp. 121140. Date of Electronic Publication: 2021 Oct 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antineoplastic Agents, Phytogenic*
Paclitaxel*
Albumin-Bound Paclitaxel ; Animals ; Cell Line, Tumor ; Drug Carriers ; Isotopes ; Macaca mulatta ; Micelles ; Rats ; Rodentia ; Therapeutic Equivalency
Czasopismo naukowe
Tytuł:
[Multi-center real world study of the efficacy and safety of albumin-bound paclitaxel in the treatment of advanced breast cancer].
Autorzy:
Sang D; Department of Medical Oncology, Beijing Sanhuan Cancer Hospital, Beijing 100122, China.
Zhou H; Department of Medical Oncology, Beijing Sanhuan Cancer Hospital, Beijing 100122, China.
Zong H; Department of Medical Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Yang H; Department of Medical Oncology, Affiliated Hospital of Hebei University, Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Baoding 071000, China.
Lu QR; Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Fan SM; Department of Medical Oncology, Beijing Sanhuan Cancer Hospital, Beijing 100122, China.
Wang YC; Department of Medical Oncology, Beijing Sanhuan Cancer Hospital, Beijing 100122, China.
Song LH; Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250117, China.
Yuan P; Special Medical Department, National Cancer Center /National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 Oct 23; Vol. 43 (10), pp. 1114-1121.
Typ publikacji:
Journal Article
MeSH Terms:
Albumin-Bound Paclitaxel*
Triple Negative Breast Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Humans ; Neoplasm Recurrence, Local ; Paclitaxel
Czasopismo naukowe
Tytuł:
Paclitaxel resistance related to nuclear envelope structural sturdiness.
Autorzy:
Smith ER; Department of Obstetrics, Gynecology and Reproductive Sciences, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Wang JQ; College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
Yang DH; College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA. Electronic address: .
Xu XX; Department of Obstetrics, Gynecology and Reproductive Sciences, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA; Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Electronic address: .
Pokaż więcej
Źródło:
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy [Drug Resist Updat] 2022 Dec; Vol. 65, pp. 100881. Date of Electronic Publication: 2022 Oct 15.
Typ publikacji:
Review; Editorial
MeSH Terms:
Paclitaxel*/pharmacology
Paclitaxel*/therapeutic use
Neoplasms*/drug therapy
Neoplasms*/genetics
Humans ; Nuclear Envelope ; Taxoids ; Docetaxel ; Cisplatin ; Apoptosis ; Drug Resistance, Neoplasm/genetics
Recenzja
Tytuł:
Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy.
Autorzy:
Li B; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.; The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.
Tan T; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.; The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.
Chu W; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.; The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.
Zhang Y; Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ye Y; Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Wang S; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.; The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.
Qin Y; School of Pharmacy, Anhui Medical University, Hefei, China.
Tang J; School of Pharmacy, Anhui Medical University, Hefei, China.
Cao X; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.; The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, People's Republic of China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 75-88.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Phytogenic/*pharmacology
Drug Carriers/*chemistry
Nanoparticles/*chemistry
Paclitaxel/*analogs & derivatives
Animals ; Antineoplastic Agents, Phytogenic/administration & dosage ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Drug Liberation ; Emulsions/chemistry ; Female ; Folic Acid/chemistry ; Humans ; MCF-7 Cells ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Paclitaxel/administration & dosage ; Paclitaxel/pharmacology ; RAW 264.7 Cells ; Tumor-Associated Macrophages/drug effects ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized controlled trials.
Autorzy:
Luo C; Division of Health Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China.; Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Liang M; Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.; The Medical College of Qingdao University, Qingdao, Shandong, China.
Liu Y; Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Zheng D; Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
He Q; Department of Nephrology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Jin J; Department of Nephrology, the First People's Hospital of Hangzhou Lin'an District, Affiliated Lin'an People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2022 Dec; Vol. 44 (1), pp. 155-170.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Angioplasty, Balloon/*instrumentation
Arteriovenous Fistula/*therapy
Arteriovenous Shunt, Surgical/*adverse effects
Paclitaxel/*administration & dosage
Renal Dialysis/*adverse effects
Angioplasty, Balloon/adverse effects ; Angioplasty, Balloon/mortality ; Arteriovenous Fistula/etiology ; Arteriovenous Shunt, Surgical/mortality ; Coated Materials, Biocompatible ; Humans ; Paclitaxel/adverse effects ; Randomized Controlled Trials as Topic ; Renal Dialysis/mortality ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; Vascular Patency
Czasopismo naukowe
Tytuł:
Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma.
Autorzy:
Shen W; Pharmacy School, Jinzhou Medical University, Jinzhou, China.
Ge S; Department of Emergency Management, Liaoning Provincial Center for Disease Control and Prevention, Shenyang, China.
Liu X; Pharmacy School, Jinzhou Medical University, Jinzhou, China.
Yu Q; Pharmacy School, Jinzhou Medical University, Jinzhou, China.
Jiang X; Pharmacy School, Jinzhou Medical University, Jinzhou, China.
Wu Q; Pharmacy School, Jinzhou Medical University, Jinzhou, China.
Tian Y; Department of Medical Oncology, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Gao Y; Department of Medical Oncology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Liu Y; Pharmacy School, Jinzhou Medical University, Jinzhou, China.
Wu C; Pharmacy School, Jinzhou Medical University, Jinzhou, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 31-42.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Phytogenic/*pharmacology
Carcinoma, Hepatocellular/*pathology
Folic Acid/*chemistry
Liver Neoplasms/*pathology
Paclitaxel/*pharmacology
Animals ; Antineoplastic Agents, Phytogenic/administration & dosage ; Biomimetics ; Cell Line, Tumor ; Cell Membrane/metabolism ; Cell Survival/drug effects ; Drug Carriers/chemistry ; Drug Liberation ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Nanoparticles/chemistry ; Paclitaxel/administration & dosage ; Particle Size ; Polyethylene Glycols/chemistry ; Random Allocation ; Surface Properties ; Tumor Burden ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance.
Autorzy:
Liping Y; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Jian H; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Zhenchao T; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Yan Z; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Jing Y; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Yangyang Z; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Jing G; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Liting Q; Division of Life Sciences and Medicine, Department of Radiotherapy Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 229-237.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Phytogenic/*pharmacology
Drug Resistance, Neoplasm/*drug effects
Glutathione/*chemistry
Nanoparticle Drug Delivery System/*chemistry
Paclitaxel/*pharmacology
Resveratrol/*pharmacology
A549 Cells ; Animals ; Antineoplastic Agents, Phytogenic/administration & dosage ; Antineoplastic Agents, Phytogenic/pharmacokinetics ; Cell Survival ; Chemistry, Pharmaceutical ; Drug Carriers/chemistry ; Drug Liberation ; Drug Stability ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Paclitaxel/administration & dosage ; Paclitaxel/pharmacokinetics ; Particle Size ; Rats ; Rats, Sprague-Dawley ; Resveratrol/administration & dosage ; Resveratrol/pharmacokinetics ; Surface Properties ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Synthesis of Paclitaxel Derivatives for Remote Loading into Liposomes and Improved Therapeutic Effect.
Autorzy:
Xu X; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Liu Y; Department of Pharmaceutics, School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.
Shao S; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Li J; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xu Z; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yin Y; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Zhao L; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wang Y; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China.
Liu D; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Nov 17; Vol. 27 (22). Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Liposomes*
Paclitaxel*/pharmacology
Paclitaxel*/therapeutic use
Drug Stability ; Boronic Acids
Czasopismo naukowe
Tytuł:
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782).
Autorzy:
Leal TA; Winship Cancer Institute, Emory University, Georgia.
Sharifi MN; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Chan N; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Wesolowski R; Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Turk AA; Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
Bruce JY; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
O'Regan RM; Department of Medicine, University of Rochester, Rochester, New York, USA.
Eickhoff J; Department of Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Barroilhet LM; Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Malhotra J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Mehnert J; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, New York City, USA.
Girda E; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Wiley E; Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Schmitz N; School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
Andrews S; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Liu G; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Wisinski KB; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2022 Nov; Vol. 11 (21), pp. 3969-3981. Date of Electronic Publication: 2022 Apr 08.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Neoplasms*/drug therapy
Neoplasms*/pathology
Paclitaxel*
Humans ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin ; Poly(ADP-ribose) Polymerases
Czasopismo naukowe
Tytuł:
Anti-cancer effects of human placenta-derived amniotic epithelial stem cells loaded with paclitaxel on cancer cells.
Autorzy:
Babajani A; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Manzari-Tavakoli A; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Jamshidi E; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tarasi R; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Niknejad H; Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Oct 28; Vol. 12 (1), pp. 18148. Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Paclitaxel*/pharmacology
Paclitaxel*/metabolism
Neoplasms*/metabolism
Humans ; Culture Media, Conditioned/pharmacology ; Drug Delivery Systems/methods ; Apoptosis ; Stem Cells/metabolism ; Epithelial Cells/metabolism
Czasopismo naukowe
Tytuł:
Drug-Coated Balloons: Drugs Beyond Paclitaxel?
Autorzy:
Haase T; Experimental Radiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; InnoRa GmbH, 10115 Berlin, Germany.
Speck U; Experimental Radiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Bienek S; InnoRa GmbH, 10115 Berlin, Germany.
Löchel M; InnoRa GmbH, 10115 Berlin, Germany.
Brunacci N; InnoRa GmbH, 10115 Berlin, Germany.
Gemeinhardt O; Experimental Radiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Schütt D; InnoRa GmbH, 10115 Berlin, Germany.
Bettink S; Clinical and Experimental Interventional Cardiology, University of Saarland, 66421 Homburg/Saar, Germany.
Kelsch B; Experimental Radiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; InnoRa GmbH, 10115 Berlin, Germany.
Scheller B; Clinical and Experimental Interventional Cardiology, University of Saarland, 66421 Homburg/Saar, Germany.
Schnorr B; Experimental Radiology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Pokaż więcej
Źródło:
Frontiers in bioscience (Landmark edition) [Front Biosci (Landmark Ed)] 2022 Oct 10; Vol. 27 (10), pp. 283.
Typ publikacji:
Journal Article
MeSH Terms:
Paclitaxel*/pharmacology
Angioplasty, Balloon, Coronary*/methods
Swine ; Animals ; Constriction, Pathologic/drug therapy ; Stents ; Coated Materials, Biocompatible/pharmacology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
7-Chloro-4-(Phenylselanyl) Quinoline Is a Novel Multitarget Therapy to Combat Peripheral Neuropathy and Comorbidities Induced by Paclitaxel in Mice.
Autorzy:
Paltian JJ; Programa de Pós-Graduação Em Bioquímica E Bioprospecção, Laboratório de Pesquisa Em Farmacologia Bioquímica (LaFarBio), Centro de Ciências Químicas, Farmacêuticas E de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Dos Reis AS; Programa de Pós-Graduação Em Bioquímica E Bioprospecção, Laboratório de Pesquisa Em Farmacologia Bioquímica (LaFarBio), Centro de Ciências Químicas, Farmacêuticas E de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Martins AWS; Programa de Pós-Graduação Em Biotecnologia, Laboratório de Genômica Estrutural, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Blödorn EB; Programa de Pós-Graduação Em Biotecnologia, Laboratório de Genômica Estrutural, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Dellagostin EN; Programa de Pós-Graduação Em Biotecnologia, Laboratório de Genômica Estrutural, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Soares LK; Programa de Pós-Graduação Em Química, Laboratório de Síntese Orgânica Limpa (LaSOL), Centro de Ciências Químicas, Farmacêuticas E de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Schumacher RF; Programa de Pós-Graduação Em Química, Departamento de Química, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
Campos VF; Programa de Pós-Graduação Em Biotecnologia, Laboratório de Genômica Estrutural, Centro de Desenvolvimento Tecnológico, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Alves D; Programa de Pós-Graduação Em Química, Laboratório de Síntese Orgânica Limpa (LaSOL), Centro de Ciências Químicas, Farmacêuticas E de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil.
Luchese C; Programa de Pós-Graduação Em Bioquímica E Bioprospecção, Laboratório de Pesquisa Em Farmacologia Bioquímica (LaFarBio), Centro de Ciências Químicas, Farmacêuticas E de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil. cristiane_.
Wilhelm EA; Programa de Pós-Graduação Em Bioquímica E Bioprospecção, Laboratório de Pesquisa Em Farmacologia Bioquímica (LaFarBio), Centro de Ciências Químicas, Farmacêuticas E de Alimentos, Universidade Federal de Pelotas, Pelotas, RS, Brazil. .
Pokaż więcej
Źródło:
Molecular neurobiology [Mol Neurobiol] 2022 Oct; Vol. 59 (10), pp. 6567-6589. Date of Electronic Publication: 2022 Aug 15.
Typ publikacji:
Journal Article
MeSH Terms:
Paclitaxel*/adverse effects
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/drug therapy
Adenosine Triphosphatases ; Animals ; Male ; Mice ; Quality of Life ; Quinolines
Czasopismo naukowe
Tytuł:
Production of paclitaxel-loaded PEG-b-PLA micelles using PEG for drug loading and freeze-drying.
Autorzy:
Rasoulianboroujeni M; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705, United States.
Repp L; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705, United States.
Lee HJ; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705, United States.
Kwon GS; Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, 777 Highland Avenue, Madison, WI 53705, United States. Electronic address: .
Pokaż więcej
Źródło:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2022 Oct; Vol. 350, pp. 350-359. Date of Electronic Publication: 2022 Aug 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Micelles*
Paclitaxel*
Drug Carriers ; Particle Size ; Polyesters ; Polyethylene Glycols ; Polymers ; Solvents
Czasopismo naukowe
Tytuł:
A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line consolidation after carboplatin, paclitaxel, and bevacizumab in newly diagnosed patients with mullerian tumors.
Autorzy:
Campos S; Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, YC1420, Boston, MA, 02215, USA. Susana_.
Matulonis U; Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, YC1420, Boston, MA, 02215, USA.
Berlin S; Hematology Oncology, Lahey Health, 6 Tsienneto Rd Suite 101LL, Derry, NH, 03038, USA.
Horowitz N; Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, YC1420, Boston, MA, 02215, USA.
Liu J; Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, YC1420, Boston, MA, 02215, USA.
Krasner C; Gillette Center for Women's Cancers, Massachusetts General Hospital, 32 Fruit Street, Boston, MA, 02114, USA.
Hang L; Gillette Center for Women's Cancers, Massachusetts General Hospital, 32 Fruit Street, Boston, MA, 02114, USA.
Zarwan C; 41 Burlington Mail Road, Burlington, MA, 01805, USA.
Barry W; Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, YC1420, Boston, MA, 02215, USA.; Rho Federal Systems Division, Inc., 2635 E. NC Hwy 54, Durham, NC, 27713, USA.
Colella T; Gillette Center for Women's Cancers, Massachusetts General Hospital, 32 Fruit Street, Boston, MA, 02114, USA.
Whalen C; Gynecologic Oncology Program, Dana-Farber Cancer Institute, 450 Brookline Ave, DA117, Boston, MA, 02215, USA.
Shoni M; Obstetrics and Gynecology, Boston Medical Center, 88 Newton St. #2118, Boston, MA, 02118, USA.
Lundquist C; PACE Center-Clinical Research, Tufts Medical Center, 800 Washington St., Box 63, Boston, MA, 02111, USA.
Birrer MJ; Women's Cancer Clinic-Gynecology, University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, 449 Jack Stephens Drive, Little Rock, AR, 72205, USA.
Penson R; Gillette Center for Women's Cancers, Massachusetts General Hospital, 32 Fruit Street, Boston, MA, 02114, USA.
Pokaż więcej
Źródło:
International journal of clinical oncology [Int J Clin Oncol] 2022 Dec; Vol. 27 (12), pp. 1881-1890. Date of Electronic Publication: 2022 Nov 08.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Paclitaxel*/adverse effects
Neoplasms*/etiology
Humans ; Carboplatin/adverse effects ; Bevacizumab/adverse effects ; Erlotinib Hydrochloride/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Tytuł:
Paclitaxel extravasation treated with systemic corticosteroids.
Autorzy:
Cheour M; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Belajouza C; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Manaa L; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Lahouel M; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Fetoui NG; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Mokni S; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Ghariani N; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Aounallah A; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Denguezli M; Department of Dermatology Farhat Hached University Hospital, University of Sousse, Sousse, Tunisia.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Dec; Vol. 47 (12), pp. 2295-2296. Date of Electronic Publication: 2022 Sep 26.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Paclitaxel*/adverse effects
Antineoplastic Agents, Phytogenic*/adverse effects
Humans ; Quality of Life ; Extravasation of Diagnostic and Therapeutic Materials ; Skin
Raport
Tytuł:
Tear film substance P in patients treated with neurotoxic chemotherapy.
Autorzy:
Chiang JCB; School of Optometry & Vision Science, University of New South Wales, Sydney, Australia. Electronic address: .
Goldstein D; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia; Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia.
Trinh T; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
Au K; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
Park SB; Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Krishnan AV; Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
Markoulli M; School of Optometry & Vision Science, University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło:
Experimental eye research [Exp Eye Res] 2022 Nov; Vol. 224, pp. 109253. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/adverse effects
Paclitaxel*/adverse effects
Substance P*/analysis
Humans ; Biomarkers/analysis ; Cornea/metabolism ; Cross-Sectional Studies ; Oxaliplatin/adverse effects ; Tears/chemistry
Czasopismo naukowe
Tytuł:
Repurposing Cyanine Photoinstability To Develop Near-Infrared Light-Activatable Nanogels for In Vivo Cargo Delivery.
Autorzy:
Tapia Hernandez R; Department of Chemistry, Beckman Institute for Advanced Science and Technology, and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Lee MC; Department of Chemistry, Beckman Institute for Advanced Science and Technology, and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Yadav AK; Department of Chemistry, Beckman Institute for Advanced Science and Technology, and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Chan J; Department of Chemistry, Beckman Institute for Advanced Science and Technology, and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Pokaż więcej
Źródło:
Journal of the American Chemical Society [J Am Chem Soc] 2022 Oct 05; Vol. 144 (39), pp. 18101-18108. Date of Electronic Publication: 2022 Sep 25.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Repositioning*
Paclitaxel*/pharmacology
Animals ; Coloring Agents ; Cytotoxins ; Mice ; Nanogels
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz